84 results
8-K
EX-10.1
RSLS
ReShape Lifesciences Inc.
29 Nov 23
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
RSLS
ReShape Lifesciences Inc.
22 Sep 23
ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System
4:02pm
8-K
EX-10.1
RSLS
ReShape Lifesciences Inc.
26 Apr 23
ReShape Lifesciences Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
4:06pm
8-K
EX-10.1
32xn42o
20 Dec 22
Departure of Directors or Certain Officers
5:30pm
8-K
EX-10.2
see o1kpvr
14 Nov 22
ReShape Lifesciences Announces $750,000 Registered Direct Offering
6:19am
8-K
EX-10.1
x2msvp u3
14 Nov 22
ReShape Lifesciences Announces $750,000 Registered Direct Offering
6:19am
8-K
EX-10.2
x0f26
2 Aug 22
ReShape Lifesciences Announces Appointment of Paul F. Hickey as President and Chief Executive Officer
4:09pm
8-K
EX-10.1
mvunc93ocx0i71
2 Aug 22
ReShape Lifesciences Announces Appointment of Paul F. Hickey as President and Chief Executive Officer
4:09pm
8-K
EX-10.1
febsy
23 Jun 22
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-10.1
4sevvqqyru970l7qx mh
19 Jul 21
Entry into a Material Definitive Agreement
8:01am
8-K
EX-10.1
qg6pii06ro51
2 Jul 21
Entry into a Material Definitive Agreement
4:05pm
S-4
EX-10.35
n5mdstwr21
30 Mar 21
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.39
lf9xp3n9
30 Mar 21
Registration of securities issued in business combination transactions
12:00am